C Bonifati Selected Research

C Bonifati Research Topics

8	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022 - 05/2006
4	Psoriatic Arthritis 11/2020 - 05/2010
2	Necrosis 03/2015 - 06/2010
2	Neoplasms (Cancer) 12/2013 - 01/2012
1	Arthritis (Polyarthritis) 03/2015
1	Disease Progression 01/2014
1	Inflammation (Inflammations) 05/2012
1	Oligodendroglioma 01/2012
1	Glioma (Gliomas) 01/2012
1	Tuberculosis (Tuberculoses) 04/2011
1	Hepatitis B 06/2010
1	Sarcoidosis (Schaumann Disease) 05/2010
1	Pulmonary Sarcoidosis 05/2010
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2006
1	Skin Diseases (Skin Disease) 05/2006
1	Peritonitis 01/2006
1	Infections 01/2006
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 11/2005
1	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 11/2005
1	Blister (Bulla) 11/2005

3	Infliximab (Remicade)FDA Link 01/2014 - 11/2005
2	Biological ProductsIBA 04/2022 - 03/2015
2	Etanercept (Enbrel)FDA Link 11/2020 - 01/2014
2	Pharmaceutical PreparationsIBA 11/2020 - 01/2012
2	CytokinesIBA 04/2011 - 11/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2011 - 05/2010
1	Messenger RNA (mRNA)IBA 10/2022
1	COVID-19 VaccinesIBA 10/2022
1	BNT162 VaccineIBA 04/2022
1	VaccinesIBA 04/2022
1	etanercept biosimilar SB4IBA 11/2020
1	Ustekinumab (CNTO 1275)FDA Link 03/2015
1	Adalimumab (Humira)FDA Link 01/2014
1	Interleukin-22 (IL-22)IBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Epidermal Growth Factor (EGF)IBA 12/2013
1	ametantrone (HAQ)IBA 05/2012
1	Bevacizumab (Avastin)FDA Link 01/2012
1	Antineoplastic Agents (Antineoplastics)IBA 01/2012
1	AntigensIBA 04/2011
1	Angiotensin Receptor AntagonistsIBA 10/2006
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2006
1	ORALIT (ORS)IBA 05/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2006
1	Anti-Infective Agents (Microbicides)IBA 01/2006
1	Mupirocin (Bactroban)FDA LinkGeneric 01/2006